Ron Jackson has over 20 years of experience leading specialty sales teams in a range of therapeutic areas covering both the hospital and outpatient settings. He joined Paratek as Vice President of National Sales in 2018. Before coming to Paratek, Ron spent 14 years at Endo Health Solutions in various leadership positions spanning the commercial sales teams, as well as, the channel account team. For the past four years, Ron served as National Sales Director, where he led a 400 person sales force and successfully launched multiple products. Prior to Endo, Ron held various leadership positions during his tenure at Pfizer/Pharmacia. Throughout his career, Ron has been recognized for his accomplishments in numerous ways, including Circle Of Excellence; Excellence in Leadership Award; Cross-Functional Award; and Living Our Values Award. Ron holds a Bachelor of Business Administration in Marketing from Baylor University, as well as, having studied leadership and strategy in Pharmaceuticals and Biotech at Harvard University and Value Creation at The Wharton School.
Jonathan Light joined Paratek in August 2017 with over a decade of experience counseling pharmaceutical companies including the support of more than a half dozen commercial product launches across multiple therapeutic areas. Jonathan was previously an Executive Counsel at Teva Pharmaceuticals where he supported the company’s brand oncology, respiratory and biologics business units which generated over $1B in annual revenue. Prior to Teva, Jonathan counseled the GI business unit at Shire and defended numerous healthcare companies as a litigator at Morgan Lewis. Jonathan’s areas of expertise include fraud and abuse laws, compliance program development and implementation, market access contracting, FDA, CMS and OIG guidance, advertising and promotion regulations, and commercial agreements. He received his J.D. from The University of Virginia School of Law, his B.A from Dartmouth College and has Bar Admissions in Pennsylvania and the United States District Court for the Eastern District of Pennsylvania.
|Jeanne Jew joined Paratek in July 2015. Ms. Jew has more than 20 years of experience in business development, product planning and general management in the biotechnology industry. Prior to joining Paratek, Ms. Jew was Senior Vice President, Business Development of KaloBios Pharmaceutical where she was responsible for business development, strategic planning, and marketing. During her tenure at KaloBios, Ms. Jew was responsible for the execution and management of its partnership with Sanofi Pasteur, and played in key role in the IPO. From 2002-2007, Ms. Jew served as Vice President of Corporate Development of Onyx Pharmaceuticals, where she was responsible for all business development activities and commercial planning for Nexavar. Prior to Onyx Pharmaceuticals, Ms. Jew held business development positions at Coulter Pharmaceuticals and became Vice President, Business Development following the acquisition of Coulter Pharmaceutical by Corixa Corporation. Earlier in her career, Ms. Jew held business development positions at Scios, Inc. and Genentech, Inc. Ms. Jew holds a Bachelor of Arts in psychology from Wesleyan University and a Master of Business Administration from Cornell University.|